CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2015	Mar. 31, 2015
CURRENT ASSETS
Cash and cash equivalents	$ 4,644,722	$ 5,014,242
Accounts receivable, net	3,654,703	3,801,584
Other receivables	514,819	208,288
Due from affiliates	20,052	36,397
Prepaid expenses	350,078	278,922
Deferred financing costs, net, current	8,235	513,646
Total current assets	9,192,609	9,853,079
Deferred financing costs, net, non-current	0	264,708
Property and equipment, net	1,219,889	582,470
Restricted cash	530,000	530,000
Intangible assets, net	1,236,622	1,377,257
Goodwill	2,168,833	2,168,833
Other assets	219,646	218,716
TOTAL ASSETS	14,567,599	14,995,063
CURRENT LIABILITIES
Accounts payable and accrued liabilities	3,712,500	3,340,594
Medical liabilities	1,939,181	1,260,549
Note and line of credit payable, net of discount, current portion	88,764	327,141
Convertible notes payable, net of discount, current portion	1,093,948	1,037,818
Total current liabilities	6,834,393	5,966,102
Notes payable, net of discount, non-current portion	0	6,234,721
Convertible notes payable, net of discount	0	1,457,103
Warrant liability	2,088,889	2,144,496
Deferred rent liability	680,336	11,610
Deferred tax liability	180,408	171,215
Total liabilities	$ 9,784,026	$ 15,985,247
COMMITMENTS, CONTINGENCIES AND SUBSEQUENT EVENTS
STOCKHOLDERS' DEFICIT
Common stock, par value $0.001; 100,000,000 shares authorized, 5,463,389 and 4,863,389 shares issued and outstanding as of December 31, 2015 and March 31, 2015, respectively	$ 5,463	$ 4,863
Additional paid-in-capital	19,418,643	16,517,985
Accumulated deficit	(24,039,865)	(19,340,521)
Stockholders' deficit attributable to Apollo Medical Holdings, Inc.	(4,615,759)	(2,817,673)
Non-controlling interest	2,321,554	1,827,489
Total stockholders' deficit	(2,294,205)	(990,184)
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' DEFICIT	14,567,599	14,995,063
MEZZANINE | Series A Preferred Stock [Member]
CURRENT LIABILITIES
Series A Preferred stock, par value $0.001; 5,000,000 shares authorized; 1,111,111 and none issued and outstanding as of December 31, 2015 and March 31, 2015, respectively. Liquidation preference of $9,999,999 and none at December 31, 2015 and March 31, 2015, respectively.	$ 7,077,778	$ 0